levodopa has been researched along with Fatigue in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (14.29) | 18.7374 |
1990's | 1 (4.76) | 18.2507 |
2000's | 5 (23.81) | 29.6817 |
2010's | 9 (42.86) | 24.3611 |
2020's | 3 (14.29) | 2.80 |
Authors | Studies |
---|---|
Kashihara, K; Maeda, T; Nakayama, T; Okuma, Y; Saiki, H; Takahashi, Y; Toyama, M; Tsuboi, Y; Yamamoto, M; Yoshida, K | 1 |
Antonini, A; Ashkan, K; Barbe, MT; Dafsari, HS; Evans, J; Fink, GR; Franklin, J; Jost, ST; Loehrer, PA; Martinez-Martin, P; Petry-Schmelzer, JN; Ray-Chaudhuri, K; Reker, P; Rizos, A; Samuel, M; Sauerbier, A; Schnitzler, A; Silverdale, M; Timmermann, L; Visser-Vandewalle, V | 1 |
An, J; Chan, P; Han, C; Jiao, L; Mao, W | 1 |
Abreu, D; Antonini, A; Chendo, I; Coelho, M; Costa, N; Fabbri, M; Ferreira, JJ; Godinho, C; Guedes, LC; Rosa, MM; Sousa, C | 1 |
Bohnen, NI; Chou, KL; Gilman, S | 1 |
Hagell, P; Iwarsson, S; Nilsson, MH; Odin, P; Rosqvist, K; Storch, A | 1 |
Benedetti, F; Carlino, E; Frisaldi, E; Guerra, G; Lopiano, L; Piedimonte, A; Romagnolo, A; Vighetti, S | 1 |
Andrea, SB; Arnold, GC; Davis, MD; Dimitrova, DM; Eaton, RW; Hammerschlag, R; Hunt, EA; Johnson, SC; Lou, JS; Nutt, J; Oken, BS | 1 |
Bassareo, PP; Cannas, A; Corona, A; Marrosu, F; Mulas, CS; Perra, S; Solla, P | 1 |
Baybas, S; Dirican, A; Dogan, GB; Dogan, VB; Koksal, A | 1 |
Herlofson, K; Larsen, JP; Ongre, SO; Tysnes, OB | 1 |
Comella, CL; Fahn, S; Friedman, JH; Marek, K; Oakes, D; Schifitto, G; Shulman, L | 1 |
Fox, SH; Lang, AE | 1 |
Celik, M; Forta, H; Kenangil, G; Orken, DN; Ur, E | 1 |
Pagonabarraga, J; Rodríguez-Oroz, MC | 1 |
Benice, T; Kearns, G; Lou, JS; Nutt, J; Oken, B; Sexton, G | 1 |
Parkes, JD | 1 |
Abele, M; Dichgans, J; Klockgether, T; Leonhardt, M; Weller, M | 1 |
Karlsen, K; Larsen, JP; Tandberg, E | 1 |
Duvoisin, RC | 1 |
Bykhovskaia, KM; Matlina, EA; Vaĭsman, SM; Vasil'ev, VN | 1 |
2 review(s) available for levodopa and Fatigue
Article | Year |
---|---|
Levodopa-related motor complications--phenomenology.
Topics: Antiparkinson Agents; Cognition Disorders; Disease Progression; Drug Administration Schedule; Dyskinesias; Fatigue; Humans; Levodopa; Mood Disorders; Motor Activity; Parkinson Disease; Treatment Failure | 2008 |
[Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages].
Topics: Antiparkinson Agents; Attention; Clinical Trials as Topic; Cognition Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Executive Function; Fatigue; Headache; Humans; Indans; Levodopa; Monoamine Oxidase Inhibitors; Motor Activity; Multicenter Studies as Topic; Nausea; Neuroprotective Agents; Parkinson Disease; Severity of Illness Index | 2013 |
4 trial(s) available for levodopa and Fatigue
Article | Year |
---|---|
A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson's disease: results at the 36-month follow-up.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Combined Modality Therapy; Deep Brain Stimulation; Fatigue; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Sleep; Subthalamic Nucleus; Treatment Outcome | 2020 |
Effect of expectancy and personality on cortical excitability in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antiparkinson Agents; Cerebral Cortex; Double-Blind Method; Evoked Potentials, Motor; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Motivation; Motor Activity; Parkinson Disease; Personality; Personality Inventory; Surveys and Questionnaires | 2013 |
Fatigue in levodopa-naive subjects with Parkinson disease.
Topics: Aged; Antiparkinson Agents; Brain; Carbidopa; Double-Blind Method; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed, Single-Photon | 2008 |
Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study.
Topics: Aged; Cross-Over Studies; Dopamine Agents; Double-Blind Method; Drug Combinations; Fatigue; Female; Fingers; Humans; Levodopa; Male; Middle Aged; Motor Activity; Movement; Muscle Contraction; Parkinson Disease; Psychomotor Performance; Regression Analysis; Surveys and Questionnaires; Time Factors | 2003 |
15 other study(ies) available for levodopa and Fatigue
Article | Year |
---|---|
Non-motor symptoms depending on motor severity in Japanese patients with Parkinson's disease: A multicenter cross-sectional study.
Topics: Cross-Sectional Studies; Fatigue; Humans; Japan; Levodopa; Parkinson Disease; Severity of Illness Index | 2020 |
Early morning off in patients with Parkinson's disease: a Chinese nationwide study and a 7-question screening scale.
Topics: Aged; China; Dystonia; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Registries; Surveys and Questionnaires | 2020 |
Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Anxiety; Blood Pressure; Cross-Sectional Studies; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Pain; Parkinson Disease; Psychiatric Status Rating Scales; Severity of Illness Index; Visual Analog Scale | 2017 |
Association between autonomic dysfunction and fatigue in Parkinson disease.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Cross-Sectional Studies; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index; Surveys and Questionnaires; Tetrabenazine | 2017 |
Dopaminergic Effect on Non-Motor Symptoms in Late Stage Parkinson's Disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Cognition Disorders; Dopamine Agents; Fatigue; Female; Humans; Levodopa; Male; Mood Disorders; Parkinson Disease; Treatment Outcome | 2018 |
Verbal communication about drug dosage balances drug reduction in Parkinson's disease: Behavioral and electrophysiological evidences.
Topics: Aged; Antiparkinson Agents; Dose-Response Relationship, Drug; Electroencephalography; Evoked Potentials; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Neurologists; Parkinson Disease; Persuasive Communication; Physician-Patient Relations; Placebo Effect; Psychomotor Performance; Severity of Illness Index | 2019 |
Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Fatigue; Female; Humans; Italy; Levodopa; Logistic Models; Male; Middle Aged; Movement Disorders; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Quality of Life | 2014 |
Independent effect of fatigue on health-related quality of life in patients with idiopathic Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Depression; Depressive Disorder; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Severity of Illness Index; Sleep Wake Disorders; Surveys and Questionnaires | 2015 |
Fatigue in early Parkinson's disease: the Norwegian ParkWest study.
Topics: Aged; Antiparkinson Agents; Dopamine Agonists; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Norway; Parkinson Disease; Prospective Studies | 2017 |
The relation of testosterone levels with fatigue and apathy in Parkinson's disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antiparkinson Agents; Fatigue; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Testosterone | 2009 |
Variability in Parkinson's disease; clinical aspects, causes and treatment.
Topics: Aging; Fatigue; Humans; Levodopa; Movement Disorders; Neurasthenia; Parkinson Disease; Sleep | 1983 |
Pathological yawning (chasm) associated with periodic leg movements in sleep: cure by levodopa.
Topics: Adult; Compulsive Behavior; Dopamine Agents; Fatigue; Female; Humans; Levodopa; Restless Legs Syndrome; Sleep Wake Disorders; Yawning | 1999 |
Clinical problems in non-fluctuating patients with Parkinson's disease: a community-based study.
Topics: Age of Onset; Aged; Antiparkinson Agents; Case-Control Studies; Dementia; Depression; Diabetes Mellitus; Drug Tolerance; Fatigue; Female; Humans; Levodopa; Male; Movement Disorders; Neurologic Examination; Norway; Outpatients; Parkinson Disease; Prevalence; Psychomotor Performance; Quality of Life; Severity of Illness Index; Sleep Wake Disorders; Surveys and Questionnaires | 2000 |
Antagonism of levodopa by papaverine.
Topics: Aged; Corpus Striatum; Fatigue; Female; Headache; Humans; Hyperhidrosis; Intracranial Arteriosclerosis; Levodopa; Papaverine; Parkinson Disease; Receptors, Drug | 1975 |
[Mechanisms of catecholamine synthesis disorders in the adrenals of rats subjected to physical fatigue].
Topics: Adrenal Glands; Animals; Catecholamines; Dopamine; Epinephrine; Fatigue; Levodopa; Male; Norepinephrine; Rats; Tyrosine | 1975 |